ERBB2 and breast cancer: To further evaluate the implications of CTC analysis in MBC setting, it was evaluated whether CTC enumeration and HER2 status findings were associated with relevant clinicopathological characteristics, including BC subtype, HER2 status in primary tumour, administrated treatment/therapeutic options and clinical stage.